With tax-based healthcare service burdened by increasingly higher costs for pharmaceuticals and the ever-more stringent regulation governing the introduction of a new drug onto the market, there is a growing trend moving from prescription (Rx) to non-prescription, over-the-counter (OTC) products. Magnus Hedman at Aurena discusses why it has turned out that the Bag-on-Valve (BoV) may in several cases be a suitable technology for products to make this switch, as marketers are looking for modern, innovative packaging that can attract consumers.

 

 

[prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2012/09/Pages-from-IPI-Volume4Issue3-44.pdf” type=”pdf”]Pages from IPI-Volume4Issue3-4[/prettyfilelink]

 

 

Comments are closed.

%d bloggers like this: